AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Calidi Biotherapeutics, Inc.

$0.69 -$18.19 (-96.36%)
AMEX · 30 Oct 2026 19:59 UTC
Previous Close
$0.67
Day Range
$0.65$0.69
Year Range
$0.62$27.04
Market Cap
1.78M
AVG Volume
262.63K
Trailing/Forward PE
-0.01/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-17
Primary Exchange
New York Stock Exchange ArcaUS
Revenue (USD) · A
020K40K60K2022202320242025
CLDI Revenue (USD) by year
PeriodRevenue (USD)
20250
20240
20230
202245K
Net Income (USD) · A
-30M-20M-10M02022202320242025
CLDI Net Income (USD) by year
PeriodNet Income (USD)
2025-19.91M
2024-22.14M
2023-29.22M
2022-25.43M
Operating Income (USD) · A
-30M-20M-10M02022202320242025
CLDI Operating Income (USD) by year
PeriodOperating Income (USD)
2025-20.24M
2024-21.78M
2023-28.99M
2022-23.13M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: CLDI

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 17 Nov 2026.

Calidi Biotherapeutics, Inc.
CLDI
Stockpicker

Video analysis: CLDI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CLDI

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.